Safety and efficacy of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study

Authors
Category Primary study
JournalJournal of the Dermatology Nurses' Association
Year 2020
This article has no abstract
Epistemonikos ID: e4dd7fd92c8b527ab23c79500095c51ad85904e8
First added on: Feb 12, 2025